You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
世衛警告全球新冠疫情有上升趨勢 Moderna及輝瑞加強針對新變種BA.2.86產生強烈抗體
世衛(WHO)警告,全球多個地區的新冠疫情有上升趨勢,估計目前全球有數十萬人因感染新冠病毒而要住院,情況令人擔憂。在北半球冬季到來前,中東及亞洲部分地區的死亡人數增加,歐洲要入住深切治療部的人數亦見上升,呼籲各國應加強疫苗接種及監測。 Moderna(MRNA.US)及輝瑞(PFE.US)表示,新冠疫苗加強針在針對高度突變的Omicron變種病毒亞型BA.2.86的測試中產生強烈的免疫反應,與未經治療的天然抗體反應相比,新加強針所產生的抗體增加 8.7倍。而輝瑞亦稱,與合作夥伴BioNTech(BNTX.US)合作開發的最新疫苗在臨床測驗中亦能產生強烈抗體反應。 美國疾控中心(CDC)此前曾表示,BA.2.86可能更容易導致曾感染過新冠病毒或之前接種過疫苗的人士感染新冠。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account